Celldex Therapeutics Stock
There is an upward development for Celldex Therapeutics compared to yesterday, with an increase of €0.76 (2.170%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Celldex Therapeutics stock is not clear.
Based on the current price of €35.78 the target price of €110.00 shows a potential of 207.434% for Celldex Therapeutics which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Celldex Therapeutics stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Celldex Therapeutics in the next few years
Pros
1
Could be very worthwhile Investment >20% year
Cons
0
-
Performance of Celldex Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Celldex Therapeutics | 2.170% | -3.193% | -2.877% | 95.947% | 155.571% | 800.126% | -42.522% |
| Lipocine Inc | -3.640% | -1.584% | 9.895% | -25.821% | -7.963% | - | - |
| Acura Pharmaceuticals | -1.060% | -1.579% | -1.579% | 154.422% | 183.333% | 233.929% | -57.355% |
| Vaxart Inc. | 1.910% | 11.605% | 17.522% | - | - | - | - |
